| scholarly article | Q13442814 |
| P2093 | author name string | Sande MA | |
| Jane JA | |||
| Scheld WM | |||
| Dacey RG | |||
| Welsh JE | |||
| Winn HR | |||
| P2860 | cites work | Effect of probenecid on cerebrospinal fluid concentrations of penicillin and cephalosporin derivatives | Q30449232 |
| Clearance of bacteria from cerebrospinal fluid to blood in experimental meningitis | Q30449499 | ||
| Mecillinam-Ampicillin Synergism in Experimental Enterobacteriaceae Meningitis | Q30450457 | ||
| The absorption of labelled erythrocytes from the subarachnoid space in rabbits | Q73174334 | ||
| Effect of cortisone and hydrocortisone on piarachnoid adhesions; an experimental study | Q73839395 | ||
| ACTH and adrenal steroids in the treatment of pneumococcal meningitis in adults | Q74772554 | ||
| Treatment of pneumococcic meningitis; results when penicillin was used alone compared with those when penicillin and streptomycin were used together, with and without hydrocortisone: alternate patient studies | Q78720759 | ||
| Acute pneumococcal meningitis. The significance of mechanical factors in influencing moratality | Q78933306 | ||
| Continuous recording and control of ventricular fluid pressure in neurosurgical practice | Q79063597 | ||
| The clinical spectrum of bacterial meningitis | Q79363127 | ||
| Purulent meningitis: the pathologic basis of clinical manifestations | Q79608364 | ||
| Fibrin degradation products in the cerebrospinal fluid of patients with pneumococcal meningitis | Q33755626 | ||
| Inhibition of Penicillin Transport from the Cerebrospinal Fluid after Intracisternal Inoculation of Bacteria | Q34464786 | ||
| BACTERIAL MENINGITIS--A REVIEW OF SELECTED ASPECTS. II. SPECIAL NEUROLOGIC PROBLEMS, POSTMENINGITIC COMPLACATIONS AND CLINICOPATHOLOGICAL CORRELATIONS. | Q35497735 | ||
| Further data on the acute effect of intravenous steroids on canine CSF secretion and absorption | Q36475138 | ||
| The role of the arachnoid villus in the removal of red blood cells from the subarachnoid space. An electron microscope study in the dog. | Q36540308 | ||
| Cefamandole in the therapy of experimental pneumococcal meningitis | Q39108291 | ||
| Corticosteroid therapy of experimental hydrocephalus after intraventricular-subarachnoid haemorrhage | Q39382878 | ||
| Review of Spinal Fluid Physiology: Production and Absorption in Relation to Pressure | Q39712255 | ||
| Basic physiology of cerebrospinal fluid outflow | Q39712388 | ||
| Transport processes in the formation of the cerebrospinal fluid | Q39775332 | ||
| Corticosteroids as Adjunctive Therapy for Acute Bacterial Meningitis | Q39804397 | ||
| The third circulation revisited | Q39938236 | ||
| Experimental Pneumococcal Meningitis. II. Characterization and Quantitation of the Inflammatory Process | Q39957638 | ||
| Bacterial meningitis; a review of 356 cases with special reference to corticosteroid and antiserum treatment | Q40056451 | ||
| Postmeningitic Hydrocephalus in Infancy Ventriculography with Special Reference to Ventricular Septa | Q40701816 | ||
| Neurological sequelae of septic meningitis. A follow-up study of 65 children | Q41685323 | ||
| Acute bacterial meningitis: an analysis of factors influencing prognosis | Q43494473 | ||
| Modulation of CSF production by alterations in cerebral perfusion pressure | Q44540101 | ||
| Dexamethasone in the treatment of acute bacterial meningitis: the effect of study design on the interpretation of results | Q44797475 | ||
| The Effect of Glucocorticoids on CSF Flow in Dogs | Q44945385 | ||
| Pneumonococcal meningitis-a killing disease | Q45245903 | ||
| Cerebrospinal Fluid Flow Alterations in the Dog with Chemical Meningitis | Q48015384 | ||
| Intracranial subarachnoid pressure recording: experience with 650 patients | Q48280476 | ||
| Tracing the bulk outflow route of cerebrospinal fluid by transmission and scanning electron microscopy | Q48505489 | ||
| The pathophysiology of bacterial meningitis and cerebral abscesses: an anatomical interpretation | Q48591981 | ||
| Surgical aspects of nontuberculous bacterial meningitis in infancy and childhood. The successful use of conservative surgery in management of some of its complications | Q48629906 | ||
| A subarachnoid screw for monitoring intracranial pressure. Technical note | Q48634216 | ||
| The mechanism of drainage of the cerebrospinal fluid | Q48656292 | ||
| Cranial and spinal components of the cerebrospinal fluid pressure-volume curve | Q48693009 | ||
| Temperature and cerebrospinal fluid production rate | Q48760875 | ||
| The mechanism of drainage of the cerebrospinal fluid | Q48944709 | ||
| Experimental pneumococcal meningitis. Permeability changes influencing the concentration of sugars and macromolecules in cerebrospinal fluid | Q49132842 | ||
| The Response of Experimental Cerebral Edema to Glucosteroid Administration | Q51235764 | ||
| The cerebrospinal fluid valves. | Q51307242 | ||
| Regulation of intracranial pressure in rat, dog, and man | Q52798284 | ||
| Compartmental analysis of compliance and outflow resistance of the cerebrospinal fluid system | Q52866563 | ||
| Evaluation of the changes of cerebrospinal fluid movement associated with meningitis: a cisternographic analysis. | Q54735585 | ||
| Pneumococcal meningitis | Q66706836 | ||
| Cerebrospinal fluid conductance and compliance of the craniospinal space in normal-pressure hydrocephalus. A comparison between two methods for measuring conductance to outflow | Q66927169 | ||
| Ultrastructural observations in experimental hydrocephalus in the rabbit | Q66981321 | ||
| Brain edema | Q67258162 | ||
| Experimental pneumococcal meningitis. IV. The effect of methyl prednisolone on meningeal inflammation | Q67328786 | ||
| Mechanism for intracranial hypertension during experimental subarachnoid hemorrhage: acute malfunction of arachnoid villi by components of plasma | Q67461531 | ||
| The surface characteristics of arachnoid granulations | Q69781686 | ||
| Corticosteroids as an adjunct to treatment in bacterial meningitis. A controlled clinical trial | Q69881209 | ||
| Functional Ultrastructure of the Arachnoid Villus | Q70496376 | ||
| A flow of cerebrospinal fluid along the central canal of the spinal cord of the rabbit and communications between this canal and the sacral subarachnoid space | Q72697761 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | penicillin | Q12190 |
| meningitis | Q48143 | ||
| cerebrospinal fluid | Q54196 | ||
| methylprednisolone | Q417222 | ||
| P304 | page(s) | 243-253 | |
| P577 | publication date | 1980-08-01 | |
| P1433 | published in | Journal of Clinical Investigation | Q3186904 |
| P1476 | title | Cerebrospinal fluid outflow resistance in rabbits with experimental meningitis. Alterations with penicillin and methylprednisolone | |
| P478 | volume | 66 |
| Q63367708 | Adjunctive corticosteroids in adults with bacterial meningitis |
| Q24630702 | Adjunctive dexamethasone in bacterial meningitis: a meta-analysis of individual patient data |
| Q35615151 | Adjunctive dexamethasone treatment in acute bacterial meningitis |
| Q41371176 | Advances in the therapy for sepsis in children |
| Q49485744 | Antibiotic diffusion to central nervous system |
| Q90720728 | Antifungal Drugs: Special Problems Treating Central Nervous System Infections |
| Q52927356 | Bacterial hydrogen peroxide contributes to cerebral hyperemia during early stages of experimental pneumococcal meningitis. |
| Q33750256 | Bacterial meningitis |
| Q36895844 | Bacterial meningitis: a review of effective pharmacotherapy |
| Q38570487 | Bacterial meningitis: an update of new treatment options |
| Q40508650 | Bacterial meningitis: mechanisms of disease and therapy |
| Q38145360 | Bacterial meningitis: new therapeutic approaches |
| Q30449424 | Bactericidal versus bacteriostatic antibiotic therapy of experimental pneumococcal meningitis in rabbits |
| Q38224911 | Brain edema and increased intracranial pressure in the pathophysiology of bacterial meningitis |
| Q35753985 | Brain ventricular dimensions and relationship to outcome in adult patients with bacterial meningitis |
| Q33615470 | Cerebrospinal fluid dynamics study in communicating hydrocephalus |
| Q39676532 | Chemotherapy for bacterial infections of the central nervous system. |
| Q38100704 | Clinical pharmacokinetics of antibacterials in cerebrospinal fluid. |
| Q33789458 | Clinical pharmacology of nervous system diseases |
| Q37037903 | Complement (C5)-derived chemotactic activity accounts for accumulation of polymorphonuclear leukocytes in cerebrospinal fluid of rabbits with pneumococcal meningitis |
| Q33723195 | Consensus statement on diagnosis, investigation, treatment and prevention of acute bacterial meningitis in immunocompetent adults. British Infection Society Working Party |
| Q24187220 | Corticosteroids for acute bacterial meningitis |
| Q24202288 | Corticosteroids for acute bacterial meningitis |
| Q24235514 | Corticosteroids for acute bacterial meningitis |
| Q24246234 | Corticosteroids for acute bacterial meningitis |
| Q24247963 | Corticosteroids for acute bacterial meningitis |
| Q33617457 | Current concepts in bacterial meningitis |
| Q47953009 | Cytokines and blood-brain barrier permeability |
| Q88502916 | Dexamethasone Administration and Mortality in Patients with Brain Abscess: A Systematic Review and Meta-Analysis |
| Q36441437 | Dexamethasone in adults with community-acquired bacterial meningitis |
| Q35649985 | Dexamethasone therapy for bacterial meningitis: Better never than late? |
| Q42223281 | Dexamethasone treatment and prognostic factors in community-acquired bacterial meningitis: a Danish retrospective population-based cohort study |
| Q63367706 | Dexamethasone treatment in adults with pneumococcal meningitis: risk factors for death |
| Q36577357 | Drug Insight: adjunctive therapies in adults with bacterial meningitis |
| Q30451354 | Effect of methylprednisolone on entry of ampicillin and gentamicin into cerebrospinal fluid in experimental pneumococcal and Escherichia coli meningitis |
| Q35552885 | Effect of recombinant human tumor necrosis factor-alpha on cerebral oxygen uptake, cerebrospinal fluid lactate, and cerebral blood flow in the rabbit: role of nitric oxide |
| Q40768757 | Evolving concepts in pediatric bacterial meningitis--Part II: Current management and therapeutic research |
| Q51798175 | Experimental bacterial meningitis in the rabbit: cerebrospinal fluid changes and its relation to leukocyte response. |
| Q39737366 | Experimental models of CNS infections. Contributions to concepts of disease and treatment. |
| Q41841795 | Experimental pneumococcal meningitis causes central nervous system pathology without inducing the 72-kd heat shock protein |
| Q40183887 | Experimental pneumococcal meningitis: role of leukocytes in pathogenesis. |
| Q30304438 | Factors associated with hydrocephalus after aneurysmal subarachnoid hemorrhage |
| Q33480896 | Fulminating haemophilus influenzae b meningitis. |
| Q34169253 | Gentamicin penetration into cerebrospinal fluid in experimental Haemophilus influenzae meningitis |
| Q30449332 | Haemophilus influenzae lipopolysaccharide-induced blood brain barrier permeability during experimental meningitis in the rat. |
| Q37028903 | Hydrocephalus is a rare outcome in community-acquired bacterial meningitis in adults: a retrospective analysis |
| Q40331657 | Improved outcome of bacterial meningitis associated with use of corticosteroid treatment |
| Q39415257 | In children with bacterial meningitis, does the addition of dexamethasone to an antibiotic treatment regimen result in a better clinical outcome than the antibiotic regimen alone?: Part A: Evidence-based answer and summary |
| Q42212000 | Listeria monocytogenes meningoencephalitis in adults: analysis of factors related to unfavourable outcome. |
| Q34243563 | Loss of cerebrovascular autoregulation in experimental meningitis in rabbits |
| Q96134827 | Magnetic Resonance Imaging Cerebrospinal Fluid Hydrodynamics in Patients with Meningitis |
| Q71313841 | Meningitis |
| Q30773702 | Meningitis and encephalitis in children. An update |
| Q37772912 | Meningitis due to group C Streptococcus: a case report and review of the literature |
| Q39730788 | Modeling of transfer kinetics at the serum-cerebrospinal fluid barrier in rabbits with experimental meningitis: application to grepafloxacin |
| Q30449385 | Morphologic alterations of the blood-brain barrier with experimental meningitis in the rat. Temporal sequence and role of encapsulation |
| Q54604855 | Morphological modifications of the choroid plexus in a rodent model of acute ventriculitis induced by gram-negative liquoral sepsis. Possible implications in the pathophysiology of hypersecretory hydrocephalus. |
| Q50436384 | Nationwide implementation of adjunctive dexamethasone therapy for pneumococcal meningitis |
| Q28079392 | Nonsurgical therapy for hydrocephalus: a comprehensive and critical review |
| Q37683101 | Pathogenesis and pathophysiology of bacterial CNS infections |
| Q30450181 | Pathogenesis and pathophysiology of bacterial meningitis |
| Q35017740 | Pathogenesis and pathophysiology of pneumococcal meningitis |
| Q33724660 | Pathogenesis of bacterial meningitis |
| Q40201732 | Pathogenesis of bacterial meningitis: contributions by experimental models in rabbits |
| Q40254974 | Pathophysiological correlates in bacterial meningitis |
| Q34142328 | Penetration of drugs through the blood-cerebrospinal fluid/blood-brain barrier for treatment of central nervous system infections |
| Q48369007 | Pharmacokinetic optimisation of the treatment of bacterial central nervous system infections |
| Q48385324 | Pharmacokinetic quantification of the exchange of drugs between blood and cerebrospinal fluid in man. |
| Q28069383 | Pharmacokinetic, Pharmacogenetic, and Other Factors Influencing CNS Penetration of Antiretrovirals |
| Q33716133 | Phenotypic switching of Cryptococcus neoformans can produce variants that elicit increased intracranial pressure in a rat model of cryptococcal meningoencephalitis |
| Q42104254 | Pneumococcal cell wall-induced meningitis impairs adult hippocampal neurogenesis |
| Q40176746 | Principles in the treatment of bacterial meningitis |
| Q41989505 | Relationship between intracranial pressure and antifungal agents levels in the CSF of patients with cryptococcal meningitis |
| Q30449338 | Role of cerebrospinal fluid pleocytosis and Haemophilus influenzae type b capsule on blood brain barrier permeability during experimental meningitis in the rat |
| Q35681325 | Steroids in adults with acute bacterial meningitis: a systematic review |
| Q46476420 | Successful treatment of methicillin-resistant staphylococcus aureus meningitis with daptomycin |
| Q33724695 | Supportive management in bacterial meningitis |
| Q41837909 | TRAIL limits excessive host immune responses in bacterial meningitis |
| Q70213586 | The management of fulminant meningitis in the intensive care unit |
| Q40493104 | The pathophysiology of pneumococcal meningitis. |
| Q24684269 | The role of pneumolysin in pneumococcal pneumonia and meningitis |
| Q34218327 | The trigeminovascular system in bacterial meningitis |
| Q30842137 | Triptans reduce the inflammatory response in bacterial meningitis |
| Q40883034 | Tyrosine kinase inhibition reduces inflammation in the acute stage of experimental pneumococcal meningitis |
| Q39642835 | Update on bacterial meningitis |
| Q40842373 | Vancomycin administration into the cerebrospinal fluid: a review |
| Q36429811 | What is new about idiopathic intracranial hypertension? An updated review of mechanism and treatment |
Search more.